AIP Insider Notice: 2,278 Shares from RSUs to Be Sold on NASDAQ

Rhea-AI Filing Summary

Arteris, Inc. (AIP) Form 144 notice reports a proposed sale of 2,278 common shares with an aggregate market value of $19,568.02. The shares represent part of the company's 42,649,917 outstanding common shares and are scheduled for sale on 09/09/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The filer acquired these shares as Restricted Stock Units on 04/01/2025, with payment dated the same day. The filing also lists four secondary sales by the same person in the prior three months totaling 6,170 shares for gross proceeds of $65,374.37.

Positive

• Required disclosure provided: The Form 144 lists the number of shares, market value, acquisition details, broker, and sale date.
• Acquisition is transparent: Shares were acquired as Restricted Stock Units on 04/01/2025, with payment date shown.

Negative

• Insider sales reported: The filer sold 6,170 shares in the past three months and plans to sell 2,278 more (facts disclosed in the filing).
• Limited signer detail: The supplied content does not include the actual signature name or date of notice in the visible fields.

Insights

Securities Analyst

TL;DR: Insider filed a Form 144 to sell 2,278 RSU-derived shares valued at $19,568 on NASDAQ; recent 3-month sales are disclosed.

The filing documents a proposed Rule 144 sale of shares acquired as Restricted Stock Units on 04/01/2025. The broker listed is Morgan Stanley Smith Barney LLC and the sale is scheduled for 09/09/2025. The filer also reported four prior sales in the past three months totaling 6,170 shares for $65,374.37 in gross proceeds. This is a routine Form 144 disclosure required for certain officer/director/affiliate transactions and provides transparency on timing and amounts.

Corporate Governance Expert

TL;DR: Form 144 provides required public notice of proposed insider sale and recent 10b5-1 and direct sales by the same individual.

The document shows the seller relied in part on 10b5-1 sales previously (explicitly labeled for two entries) and lists both plan-driven and direct sales by the same individual. It includes acquisition method (Restricted Stock Units) and exact dates, satisfying disclosure requirements. The notice contains no statements about any undisclosed material adverse information; signature and attestations are referenced but no signer name is provided in the content supplied.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2278	19568.02	42649917	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted Stock Units	Issuer			2278	04/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/08/2025	424	3807.52
PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	258	2306.96
10b5-1 Sales for PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/03/2025	3609	33370.77
PAUL LAWRENCE ALPERN 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/02/2025	2879	25889.12

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arteris (AIP) Form 144 disclose?

The Form 144 discloses a proposed sale of 2,278 common shares valued at $19,568.02, acquired as RSUs on 04/01/2025, to be sold on 09/09/2025 via Morgan Stanley Smith Barney LLC.

How many shares has the filer sold in the past three months?

The filing lists four sales in the past three months totaling 6,170 shares for gross proceeds of $65,374.37.

Who is the broker for the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, with an address at 1 New York Plaza, 8th Floor, New York, NY 10004.

When were the shares being sold acquired?

The shares to be sold were acquired on 04/01/2025 as Restricted Stock Units and show a payment date of 04/01/2025.

Are there 10b5-1 sales noted in the filing?

Yes; the filing explicitly labels certain prior transactions as 10b5-1 Sales for the filer.